A Randomized, Controlled Trial to Evaluate CT Image Quality Lumentin® 44

An Open, Randomized, Controlled, Single Centre Trial to Evaluate CT Image Quality and Diagnostic Feasibility of Lumentin® 44, in Comparison With Omnipaque and Movprep.

Subjects referred for abdominal or thoracoabdominal CT-examination will be randomised to either the three contrast agents Lumentin® 44, Omnipaque® or Movprep. The difference in contrast density, as observed in the CT-examination, between lumen and wall (mucosal lining) will be compared by the three contrast agents.

Inclusion Criteria:

• Subjects of either gender at least 18 years at the time of signing the informed consent.
• Having a clinical indication for CT-examination of the abdomen

Exclusion Criteria:

• IV administration of iodine is contraindicated
• Known allergy to egg albumen
• Clinical suspicion, according to medical record, of fistula formation and/or leakage
• Referral indication of small bowel disease(s)
• Having known manifest thyrotoxicosis
• Having known phenylketonuria
• Having known Glucose-6-phosphatase deficiency